← SynDRA
FROVATRIPTAN
SynDRA canonical compound SYN0005003 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR1A | HTR1B | HTR1D |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
| Indication | migraine headache |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- HTR1B AGONIST
- Serotonin 1b (5-HT1b) receptor agonist
- HTR1D AGONIST
- Serotonin 1d (5-HT1d) receptor agonist
- serotonin receptor agonist
- HTR1B MODULATOR
- HTR1D MODULATOR
Drug classes
- Neurotransmitter Agents
- Serotonin Agents
- Serotonin Receptor Agonists
- Serotonin 1b Receptor Agonists
- Serotonin 1d Receptor Agonists
- Serotonin-1b and Serotonin-1d Receptor Agonist
ATC classes
- N02C · ANTIMIGRAINE PREPARATIONS
Cross-references
Synonyms
- (R)-Frovatriptan
- frovatriptan succinate
- frovatriptan succinate hydrate
- SB 209509
- VML251
- Allergo filmtabletten
- Migard
- Mylatrip
- Allegro
- Auradol
- Frova
- Frovelan
- Miguard
- Rilamig
- SB-209509
- Allergo filmtabletten(TN)
- Frova (TN)
- Frovatriptan (INN)
- (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide
- (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
- (R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide
- H82Q2D5WA7
- miguard
- 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole
- frovatriptanum
- RefChem:56375
- DTXCID703080
- N02CC07
- frova
- FROVATRIPTAN [INN]
- R-Frovatriptan
- HSDB 7363
- Frovatriptan [INN:BAN]
- UNII-H82Q2D5WA7
- FROVATRIPTAN [MI]
- FROVATRIPTAN [HSDB]
- Allergo filmtabletten (TN)
- (R)-Frovatriptan;SB209509;SB-209509;SB 209509
Reported adverse events
- Dizziness
- Fatigue
- Chest pain
- Dyspepsia
- Flushing
- Seizure
- Arrhythmia
- Dry mouth
- Headache
- Heart rate
- Hypersensitivity
- Pain
Look up FROVATRIPTAN in the interactive SynDRA portal →